Wang, H, et al.
Trends in invasive Haemophilus influenzae type B disease in Australia, 1995–2005. Communicable Diseases Intelligence Quarterly Report
2008; 32: 316–325.
Peltola, H. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clinical Microbiology Reviews
2000; 13: 302–317.
Agrawal, A, Murphy, TF.
Haemophilus influenzae infections in the H. influenzae type b conjugate vaccine era. Journal of Clinical Microbiology
2011; 49: 3728–3732.
Ladhani, SN, et al.
Invasive Haemophilus influenzae serotype e and f disease, England and Wales. Emerging Infectious Diseases
2012; 18: 725–732.
Resman, F, et al.
Invasive disease caused by Haemophilus influenzae in Sweden 1997–2009; evidence of increasing incidence and clinical burden of non-type b strains. Clinical Microbiology and Infection
2011; 17: 1638–1645.
McConnell, A, et al.
Invasive infections caused by Haemophilus influenzae serotypes in twelve Canadian IMPACT centers, 1996–2001. Pediatric Infectious Disease Journal
2007; 26: 1025–1031.
Dworkin, MS, Park, L, Borchardt, SM. The changing epidemiology of invasive Haemophilus influenzae disease, especially in persons > or = 65 years old. Clinical Infectious Diseases
2007; 44: 810–816.
Herceg, A. The decline of Haemophilus influenzae type b disease in Australia. Communicable Diseases Intelligence
1997; 21: 173–176.
Australian Government DoHaA, National Health and Medical Research Council. The Australian Immunisation Handbook, 2008.
Horby, P, et al.
Progress towards eliminating Hib in Australia: an evaluation of Haemophilus influenzae type b prevention in Australia, 1 July 1993 to 30 June 2000. Communicable Diseases Intelligence Quarterly Report
2003; 27: 324–341.
Berndsen, MR, Erlendsdottir, H, Gottfredsson, M. Evolving epidemiology of invasive Haemophilus infections in the post-vaccination era: results from a long-term population-based study. Clinical Microbiology and Infection
2012; 18: 918–923.
Adam, HJ, et al.
Changing epidemiology of invasive Haemophilus influenzae in Ontario, Canada: evidence for herd effects and strain replacement due to Hib vaccination. Vaccine
2010; 28: 4073–4078.
MacNeil, JR, et al.
Current epidemiology and trends in invasive Haemophilus influenzae disease – United States, 1989–2008. Clinical Infectious Diseases
2011; 53: 1230–1236.
Falla, TJ, et al.
PCR for capsular typing of Haemophilus influenzae
. Journal of Clinical Microbiology
1994; 32: 2382–2386.
Stralin, K, et al.
Design of a multiplex PCR for Streptococcus pneumoniae, Haemophilus influenzae, Mycoplasma pneumoniae and Chlamydophila pneumoniae to be used on sputum samples. APMIS
2005; 113: 99–111.
CLSI. M100-S24 – Performance Standards for Antimicrobial SusceptibilityTesting; Twenty-Fourth Informational Supplement.
EUCAST. The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 3.1, 2013 (http://www.eucast.org).
Rubach, MP, et al.
Increasing incidence of invasive Haemophilus influenzae disease in adults, Utah, USA. Emerging Infectious Diseases
2011; 17: 1645–1650.
Gkentzi, D, Slack, MP, Ladhani, SN. The burden of nonencapsulated Haemophilus influenzae in children and potential for prevention. Current Opinion in Infectious Diseases
2012; 25: 266–272.
Wiertsema, SP, et al.
Predominance of nontypeable Haemophilus influenzae in children with otitis media following introduction of a 3 + 0 pneumococcal conjugate vaccine schedule. Vaccine
2011; 29: 5163–5170.
Quentin, R, et al.
Typing of urogenital, maternal, and neonatal isolates of Haemophilus influenzae and Haemophilus parainfluenzae in correlation with clinical source of isolation and evidence for a genital specificity of H. influenzae biotype IV. Journal of Clinical Microbiology
1989; 27: 2286–2294.
Cherpes, TL, Kusne, S, Hillier, SL.
Haemophilus influenzae septic abortion. Infectious Diseases in Obstetrics and Gynecology
2002; 10: 161–164.
Ladhani, SN, Ramsay, M, Slack, MP. The impact of Haemophilus influenzae serotype B resurgence on the epidemiology of childhood invasive Haemophilus influenzae disease in England and Wales. Pediatric Infectious Disease Journal
2011; 30: 893–895.
van Wessel, K, et al.
Nontypeable Haemophilus influenzae invasive disease in The Netherlands: a retrospective surveillance study 2001–2008. Clinical Infectious Diseases
2011; 53: e1–7.
Collins, S, et al.
Risk of invasive Haemophilus influenzae infection during pregnancy and association with adverse fetal outcomes. Journal of the American Medical Association
2014; 311: 1125–1132.
Jacups, SP, Morris, PS, Leach, AJ.
Haemophilus influenzae type b carriage in Indigenous children and children attending childcare centers in the Northern Territory, Australia, spanning pre- and post-vaccine eras. Vaccine
2011; 29: 3083–3088.
Ulanova, M. Global epidemiology of invasive Haemophilus influenzae type a disease: do we need a new vaccine?
Journal of Vaccines
Brown, VM, et al.
Invasive Haemophilus influenzae disease caused by non-type b strains in Northwestern Ontario, Canada, 2002–2008. Clinical Infectious Diseases
2009; 49: 1240–1243.
Menzies, RI, et al.
No evidence of increasing Haemophilus influenzae non-b infection in Australian Aboriginal children. International Journal of Circumpolar Health
Satola, SW, et al.
Capsule gene analysis of invasive Haemophilus influenzae: accuracy of serotyping and prevalence of IS1016 among nontypeable isolates. Journal of Clinical Microbiology
2007; 45: 3230–3238.
Prymula, R, et al.
Impact of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) on bacterial nasopharyngeal carriage. Vaccine
2011; 29: 1959–1967.
Prymula, R, et al.
Immunological memory and nasopharyngeal carriage in 4-year-old children previously primed and boosted with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) with or without concomitant prophylactic paracetamol. Vaccine
2013; 31: 2080–2088.
Murphy, TF. Vaccine development for non-typeable Haemophilus influenzae and Moraxella catarrhalis: progress and challenges. Expert Review of Vaccines
2005; 4: 843–853.